Gertraud M. Krähn
50 works · 2,842 citations · h-index 22
Top works
- Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
- Dermatoscopy and High Frequency Sonography: Two Useful Non‐Invasive Methods to Increase Preoperative Diagnostic Accuracy in Pigmented Skin Lesions
- Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseases
- Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
- Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer
- Outdoor activities in childhood: a protective factor for cutaneous melanoma? Results of a case-control study in 271 matched pairs
- Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor
- Trauma and melanoma formation: a true association?
- Interlaboratory Evaluation of a New Reverse Transcriptase Polymerase Chain Reaction–Based Enzyme-Linked Immunosorbent Assay for the Detection of Circulating Melanoma Cells: A Multicenter Study of the Dermatologic Cooperative Oncology Group
- Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia
- Interferon gamma in survivors of the Chernobyl power plant accident: new therapeutic option for radiation-induced fibrosis
- S100 beta is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase.
- Chromosome 7 aneusomy. A marker for metastatic melanoma? Expression of the epidermal growth factor receptor gene and chromosome 7 aneusomy in nevi, primary malignant melanomas and metastases.
- S-100 protein in peripheral blood: A marker for melanoma metastases
- Chromosome 7 Aneusomy. A Marker for Metastatic Melanoma?
- Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany
- Das kutane Strahlensyndrom
- [The treatment of cutaneous radiation-induced fibrosis with pentoxifylline and vitamin E. An empirical report].
- Psoralen plus ultraviolet‐A‐bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease
- Bath-PUVA as a treatment for Pityriasis rubra pilaris provoked by ultraviolet B.